Login to Your Account

Bid Too Low, CEO Says

Languishing Stock Price Lands Unsolicited Merger Offer for YM

By Jennifer Boggs

Friday, November 14, 2008
A holding firm has put an offer on the table to buy out Canadian biotech YM BioSciences Inc., a company that, despite two late-stage products in its pipeline, has been pining for attention from an increasingly tough capital market. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription